YONEDA KAZUE

ヨネダカズエ | YONEDA KAZUE

Affiliation and department：

Research field (1)： Tumor biology

Research theme for competitive and other funds (12)：

2022 - 2025 Detection of circulating tumor cells with a novel microfluidic system in patients with lung cancer
2021 - 2024 低侵襲でハイスループットな悪性中皮腫の早期診断法の確立
2020 - 2023 胸部悪性腫瘍における免疫微小環境のモニタリングに関する研究
2019 - 2023 Elucidation of immune checkpoint inhibitor resistance mechanism in lung cancer
2019 - 2022 Detection of circulating tumor cells with novel microfluidic system in lung cancer

Show all

Papers (72)：

Masatoshi Kanayama, Rintaro Oyama, Masataka Mori, Akihiro Taira, Shinji Shinohara, Taiji Kuwata, Masaru Takenaka, Kazue Yoneda, Koji Kuroda, Takashi Ohnaga, et al. Novel circulating tumor cell-detection chip combining conventional podoplanin and EGFR antibodies for all histological malignant pleural mesothelioma. Oncology letters. 2021. 22. 1. 522-522
小山倫浩, 浦本秀隆, 米田和恵, 小山倫太郎, 金山雅俊, 篠原伸二, 竹中賢, 黒田耕志, 山下直樹, 宗哲哉, et al. 肺腺癌の癌幹細胞マーカー(Aldehyde dehydrogenase-1・CD133・CD44)と無再発生存期間(DFI)の関連. 日本癌学会総会記事. 2020. 79回. PJ14-1
小山倫浩, 浦本秀隆, 小山倫太郎, 森將鷹, 篠原伸二, 桑田泰治, 田嶋裕子, 今西直子, 米田和恵, 黒田耕志, et al. 肺腺癌における癌幹細胞マーカー(Aldehyde dehydrogenase-1、CD133、CD44)の発現. 日本外科学会定期学術集会抄録集. 2020. 120回. DP-4
小山倫浩, 浦本秀隆, 小山倫太郎, 森將鷹, 金山雅俊, 篠原伸二, 桑田泰治, 今西直子, 米田和恵, 黒田耕志, et al. 肺腺癌における癌幹細胞マーカー(Aldehyde dehydrogenase-1、CD133、CD44)発現の臨床的意義. 日本呼吸器外科学会雑誌. 2020. 34. 3. MO23-5
Masataka Mori, Yoshinobu Ichiki, Masatoshi Kanayama, Akihiro Taira, Shinji Shinohara, Taiji Kuwata, Naoko Imanishi, Kazue Yoneda, Koji Kuroda, Fumihiro Tanaka. The impact of perioperative heparin bridging therapy in lung cancer surgery. General thoracic and cardiovascular surgery. 2020. 68. 6. 623-628

ｍore...

MISC (56)：

Fumihiro Tanaka, Kazue Yoneda, Masaru Takenaka. Postoperative management for non-small cell lung cancer harboring EGFR mutations. Journal of Thoracic Disease. 2020. 12. 8. 4556-4560
Taiji Kuwata, Kazue Yoneda, Masataka Mori, Masatoshi Kanayama, Koji Kuroda, Mika K Kaneko, Yukinari Kato, Fumihiro Tanaka. Detection of Circulating Tumor Cells (CTCs) in Malignant Pleural Mesothelioma (MPM) with the "Universal" CTC-Chip and An Anti-Podoplanin Antibody NZ-1.2. Cells. 2020. 9. 4
米田和恵, 森將鷹, 金山雅俊, 桑田泰治, 平良彰浩, 黒田耕志, 田中文啓, 川波敏則, 矢寺和博, 大栗隆行. 局所進行非小細胞肺癌に対する化学放射線療法後の腫瘍免疫微小環境の変化. 肺癌(Web). 2020. 60. 3
米田和恵, 森將鷹, 金山雅俊, 桑田泰治, 平良彰浩, 松宮弘喜, 名部裕介, 篠原伸二, 今西直子, 黒田耕志, et al. 局所進行非小細胞肺癌に対する化学放射線療法後の腫瘍免疫微小環境の変化. 日本肺癌学会総会号. 2019. 60th
Kazue Yoneda, Taiji Kuwata, Masatoshi Kanayama, Masataka Mori, Toshinori Kawanami, Kazuhiro Yatera, Takayuki Ohguri, Masanori Hisaoka, Toshiyuki Nakayama, Fumihiro Tanaka. Alteration in tumoural PD-L1 expression and stromal CD8-positive tumour-infiltrating lymphocytes after concurrent chemo-radiotherapy for non-small cell lung cancer. British Journal of Cancer. 2019. 121. 6. 490-496

ｍore...

Professional career (1)：

医学博士 (兵庫医科大学大学院)

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page